The International Menopause Society has brought together 7 international Societies to provide harmonised, global recommendations for the care of women at menopause:
- The 2016 Global Consensus Statement on Menopausal Hormone Therapy
This follows the International Menopause Society's most up-to-date educational resource for physicians treating women in midlife:
- 2016 IMS Recommendations on women's midlife health and menopause hormone therapy (MHT)
Global Consensus Statement
Dr Tobie de Villiers, lead author of the Consensus statement comments "The original Global Consensus on Menopausal Hormone Therapy, developed by leading menopause Societies, succeeded in presenting guidelines in a troubled therapeutic area that are helpful to both health-care providers and potential users of menopausal hormone therapy. The revised statement updates and expands the areas of consensus, but does not replace the more detailed and fully referenced recommendations of the individual societies, which are tailored to the needs of each region. Our hope is that this statement will enable health-care providers to offer those women in midlife, who may benefit from menopausal hormone therapy, the opportunity to make a fully informed decision.
Professor Rod Baber, IMS President, commented "I believe the new Global Consensus is a major step forward in the management of menopausal women as it provides women and their doctors with internationally endorsed guidance".
A Global Consensus statement on Menopausal Hormone Therapy was first published in 2013. The new 2016 Global Consensus has been endorsed by 7 international Societies including: The International Menopause Society, The North American Menopause Society, The Endocrine Society, The European Menopause and Andropause Society, The Asia Pacific Menopause Federation, The International Osteoporosis Foundation and The Federation of Latin American Menopause Societies.
The Global Consensus Statement is now available to download for free on the IMS website.
2016 IMS Recommendations on women's midlife health and menopause hormone therapy (MHT)
Professor Baber, IMS President and lead author of the IMS Recommendations reflected "The Recommendations also honour the IMS ongoing commitment to evidence-based education to improve the health of women in midlife. We encourage physicians to take the Recommendations, which have been translated into several languages, including Spanish and Chinese, to use these as educational tools around the world"
Nick Panay and Anna Fenton, co-editors of the Recommendations commented "This version of the guidelines has been updated to include new Levels of Evidence and Grades of Recommendations to reflect the latest research outcomes"
The guidelines, published in the IMS peer reviewed journal, Climacteric, are now available on the IMS website for free download. An accompanying slide kit is also available which summarises the key points of the Recommendations.
New initiative aims to support menopausal workers and reduce employer costs